ADHD Trial, Recruiting NCT06180681 Sponsor: University of California, San Diego Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06180681
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 7 to 11 years (in 2nd through 5th grade) who attend a school that is taking part in the study
  • Children who have been referred by a school mental health provider because of concerns related to ADHD
  • Children who show six or more ADHD-related symptoms (either inattention or hyperactivity/impulsivity) based on ratings from both a parent and a teacher using a standard checklist
  • Children whose ADHD-related difficulties are causing noticeable problems both at home and at school, as rated by both a parent and a teacher on a standard scale
  • Children whose caregiver and teacher have agreed to take part, and the child has also agreed to participate

Who may not be able to join:

  • Children who have conditions that would make the study's treatment unsuitable, including severe vision or hearing problems, severe delays in language or learning, psychosis, or a pervasive developmental disorder
  • Children who spend their entire school day in a specialised special education classroom
  • Children, or their parent or primary caregiver, who do not speak or read English or Spanish, as all study materials and sessions are in those two languages only
  • Children who are planning to start or stop any psychiatric medication during the study period (children who are already on stable medication for attention or behaviour may still be considered eligible, provided they meet all other entry requirements — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Miguel Villodas, Ph.D., San Diego State University

Phone: 16196513154

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability, Feasibility, and Appropriateness of Intervention Measure; Intervention Fidelity; DBRC Completion; Parenting Skill Use Diary; System Usability Scale (SUS); Sustained Use of EBP Strategies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov